Literature DB >> 1309740

Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase C.

B R Conklin1, O Chabre, Y H Wong, A D Federman, H R Bourne.   

Abstract

Gq mediates hormonal stimulation of phosphoinositide-specific phospholipase C (PI-PLC). We mutated the alpha subunit of Gq (alpha q) to replace arginine 183 with cysteine. Mutations that substitute cysteine for the corresponding arginine residues of alpha s and alpha i2 constitutively activate their respective effector pathways, creating the gsp and gip2 oncogenes. Transient expression of alpha q-R183C in COS-7 and HEK-293 cells constitutively activates PI-PLC, but wild type (WT) alpha q does not. This suggests that the mutated arginines in alpha s, alpha i2, and alpha q share a common function in regulating the active state of these proteins and that the alpha q gene may serve as a target for oncogenic mutations in human tumors. In an attempt to develop an assay for receptor stimulation of recombinant alpha q, we co-expressed receptors with alpha q-WT. We found that the alpha 2-adrenoceptor stimulates PI-PLC activation in HEK-293 cells in a fashion that depends completely on co-expression of alpha q-WT. These findings create an experimental model, similar to that provided for alpha s by S49 cyc- cells, that should make it possible to analyze receptor and effector coupling by mutant alpha q against a null background.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309740

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C.

Authors:  M K Ho; L Y Yung; J S Chan; J H Chan; C S Wong; Y H Wong
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

3.  A Gsalpha mutant designed to inhibit receptor signaling through Gs.

Authors:  T Iiri; S M Bell; T J Baranski; T Fujita; H R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain.

Authors:  V Antonelli; F Bernasconi; Y H Wong; L Vallar
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

5.  Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.

Authors:  K B Chow; Y H Wong; H Wise
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 6.  G proteins: critical control points for transmembrane signals.

Authors:  E J Neer
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

7.  Differential coupling of the formyl peptide receptor to adenylate cyclase and phospholipase C by the pertussis toxin-insensitive Gz protein.

Authors:  R C Tsu; H W Lai; R A Allen; Y H Wong
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

8.  Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor.

Authors:  Jingyan Han; Guoquan Liu; Jasmina Profirovic; Jiaxin Niu; Tatyana Voyno-Yasenetskaya
Journal:  FASEB J       Date:  2009-08-18       Impact factor: 5.191

9.  Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.

Authors:  Mariya Chhatriwala; R Gnana Ravi; Roshni I Patel; Jose L Boyer; Kenneth A Jacobson; T Kendall Harden
Journal:  J Pharmacol Exp Ther       Date:  2004-09-02       Impact factor: 4.030

10.  Identification of G alpha 11 as the phospholipase C-activating G-protein of turkey erythrocytes.

Authors:  D H Maurice; G L Waldo; A J Morris; R A Nicholas; T K Harden
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.